1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole

CAS35554-44-0
EC252-615-0

List details

Basic info

Status Opinion Adopted
Submitter Germany
Regulatory programme
  • PPP
CLP Annex VI Index Number
  • 613-042-00-5
ATP number and date ATP07 - (25/07/2015), 01/01/2017
Link to ATP

Classification

Harmonised classification at the time of the proposal
  • Acute Tox. 4*, H302
  • Acute Tox. 4*, H332
  • Eye Dam. 1, H318
  • Aquatic Acute 1, H400
  • Aquatic Chronic 1, H410
Proposed harmonised classification by the dossier submitter
  • Acute Tox. 3, H301
  • Acute Tox. 4, H332
  • Eye Dam. 1, H318
  • Aquatic Chronic 1, H410
  • Aquatic Chronic 1, M-factor=10
Proposed specific concentration limits by the dossier submitter N; R51-53: C≥ 25%; R52/53: 2.5% ≤C< 25%

Intention timeline

Date of intention 2010-09-14
Expected date of submission 2010-12-22
Submitted for accordance check 2010-11-26
Final submission date 2012-05-15
Start of consultation 2012-08-21
Deadline for commenting 2012-10-05
Date of opinion 2013-06-04
Legal deadline for opinion adoption 2014-02-21

Documents

CLH report
Comments received
RAC opinion
Background document external link [echa.europa.eu]

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

  • Biocidal active substances under the name 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil)
    Product type: PT03-Veterinary hygiene
  • Harmonised classification and labelling (CLP Annex VI) under the name imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
    Hazard Class and Category Codes: Carc. 2: Carcinogenicity; Acute Tox. 3: Acute toxicity; Acute Tox. 4: Acute toxicity; Eye Dam. 1: Serious eye damage/eye irritation; Aquatic Chronic 1: Hazardous to the aquatic environment
Add the related substance to your watchlist to monitor this regulatory record.